InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Quantum Biopharma Ltd.

QNTM Clue Score36
Ontario, Canada Fiscal year ends December CIK 0001771885
$2.89 +2.48% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.89 +95.27% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 8 Jun 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Fiscal year 2019Revenue0.3Operating income−22.5Net income−39.1Fiscal year 2020Operating income−30.7Net income−31.8Fiscal year 2021Operating income−33.7Net income−35.3Fiscal year 2022Operating income−27.4Net income−23.6Fiscal year 2023Operating income−23.8Fiscal year 2024Operating income−16.1Fiscal year 2025Operating income−15.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.3 n/a n/a n/a n/a n/a n/a
Growth
Operating income n/a −22.5 −30.7 −33.7 −27.4 −23.8 −16.1 −15.3
Net income n/a −39.1 −31.8 −35.3 −23.6 n/a n/a n/a
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Fiscal year 2019Gross margin−936.2%Operating margin−8,745.4%Net margin−15,219.6%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a −936.2% n/a n/a n/a n/a n/a n/a
Operating margin n/a −8,745.4% n/a n/a n/a n/a n/a n/a
Net margin n/a −15,219.6% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Fiscal year 2019Operating cash flow−13.7Fiscal year 2020Operating cash flow−19.1Capital expenditure0.0Free cash flow−19.1Fiscal year 2021Operating cash flow−20.7Capital expenditure0.0Free cash flow−20.7Fiscal year 2022Operating cash flow−28.3Capital expenditure−0.1Free cash flow−28.4Fiscal year 2023Operating cash flow−10.8Capital expenditure0.0Free cash flow−10.8Fiscal year 2024Operating cash flow−6.9Capital expenditure0.0Free cash flow−6.9Fiscal year 2025Operating cash flow−8.2
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a −13.7 −19.1 −20.7 −28.3 −10.8 −6.9 −8.2
Capital expenditure n/a n/a 0.0 0.0 −0.1 0.0 0.0 n/a
Free cash flow n/a n/a −19.1 −20.7 −28.4 −10.8 −6.9 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2018Cash and securities15.9Shareholders’ equity38.4Fiscal year 2019Cash and securities6.0Shareholders’ equity36.3Fiscal year 2020Cash and securities17.5Shareholders’ equity36.3Fiscal year 2021Cash and securities35.3Shareholders’ equity54.1Fiscal year 2022Cash and securities17.0Shareholders’ equity30.5Fiscal year 2023Cash and securities2.8Shareholders’ equity13.2Fiscal year 2024Cash and securities6.0Shareholders’ equity11.5Fiscal year 2025Cash and securities1.9Shareholders’ equity6.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 15.9 6.0 17.5 35.3 17.0 2.8 6.0 1.9
Shareholders’ equity 38.4 36.3 36.3 54.1 30.5 13.2 11.5 6.9

In millions of CAD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of CAD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Assets
15.9 6.0 17.5 35.3 17.0 2.8 6.0 1.9
0.7 1.6 0.2 0.5 0.4 n/a n/a n/a
0.0 0.7 0.0 n/a n/a 0.0 0.1 0.1
9.1 8.9 0.0 0.0 0.1 0.1 0.1 0.1
39.7 43.2 42.0 63.0 38.4 17.5 17.1 11.2
Growth +8.9% −2.9% +50.0% −39.0% −54.5% −2.0% −34.8%
Liabilities
1.3 6.9 5.7 8.8 7.9 4.6 6.7 6.1
Equity
−19.9 −59.1 −90.9 −126.2 −144.2 −157.9 −172.1 −198.3
38.4 36.3 36.3 54.1 30.5 13.2 11.5 6.9
Growth −5.5% +0.1% +49.1% −43.6% −56.7% −13.3% −39.7%
Per share and net cash
n/a 7.1 19.2 n/a n/a 0.0 0.0 n/a
calc n/a 5.14 1.89 n/a n/a 183,843.93 956,711.50 n/a

† The number of shares outstanding jumps at 2020 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split. This count is a different filed figure from the diluted average on the income statement, so it can break in a different year.

Lines marked calc are worked out here from filed figures; point at one for how. Shown in CAD as filed; the screener converts to dollars.